Antitumour activity of photosensitized hypericin on A431 cell xenografts

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 1619-1625

  Vandenbogaerde, Ann L ^a   Geboes, Karel R ^b   Cuveele, Joel F ^a   Agostinis, Patrizia M ^c   Merlevede, Wilfried J ^c   De Witte, Peter A ^a,d  

^a Lab V Farmaceutische Biol F   (Belgium)

^b Lab Voor Histochemie en Cytochemie   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d Faculteit Farmacie   (Belgium)

Author keywords

Hypericin; Phenanthroperylenequinone; Photodynamic therapy (PDT); Xenograft

Indexed keywords

HYPERICIN; PHOTOSENSITIZING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; IRRADIATION; LIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR VOLUME; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; CELL LINE; HUMANS; LIGHT; METABOLIC CLEARANCE RATE; MICE; MICE, NUDE; PERYLENE; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0029759692     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Meruelo D, Lavie G and Lavie D: Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin. Proc Natl Acad Sci U S A 85: 5230-5234, 1988.
2. Degar S, Prince AM, Pascual D, Lavie G, Levin B, Mazur Y, Lavie D, Ehrlich LS, Carter C and Meruelo D: Inactivation of the human immunodeficiency virus by hypericin: evidence for photochemical alterations of p24 and a block in uncoating. AIDS Res Hum Retroviruses 8: 1929-1936, 1992.
3. Lenard J, Rabson A and Vanderoef R: Photodynamic inactivation of infectivity of human immunodeficiency virus and other enveloped viruses using hypericin and rose bengal: inhibition of fusion and syncytia formation. Proc Natl Acad Sci USA 90: 158-162, 1993.
4. Thomas C, Macgill RS, Miller GC and Pardini RS: Photoactivation of hypericin generates singlet oxygen in mitochondria and inhibits succinoxidase. Photochem Photobiol 55: 47-53, 1992.
5. Thomas C and Pardini RS: Oxygen dependence of hypericin-induced phototoxicity to EMT6 mouse mammary carcinoma cells. Photochem Photobiol 55: 831-837, 1992.
6. Andreoni A, Colasanti A, Colasanti P, Mastrocinque M, Riccio P and Roberti G: Laser photosensitization of cells by hypericin. Photochem Photobiol 59: 529-533, 1994.
7. de Witte P, Agostinis P, Van Lint J, Merlevede W and Vandenheede JR: Inhibition of epidermal growth factor receptor tyrosine kinase activity by hypericin. Biochem Pharmacol 46: 1929-1936, 1993.
8. Agostinis P, Vandenbogaerde A, Donella-Deana A, Pinna LA, Lee K, Goris J, Merlevede W, Vandenheede JR and de Witte P: Photosensitized inhibition of growth-factor regulated protein kinases by hypericin. Biochem Pharmacol 49: 1615-1622, 1995.
9. Workman P, Brunton VG and Robins DJ: Tyrosine kinase inhibitors. Semin Cancer Biol 3: 369-381, 1992.
10. Okpanyi SN, Scholl BC and Miltenburger HG: Genotoxizitat eines standardisierten Hypericum-Extraktes. Arzneim -Forsch 40: 851-855, 1990.
11. Diwu Z and Lown JW: Phototherapeutic potential of alternative photosensitizers to porphyrins. Pharmacol Ther 63: 1-35, 1994.
12. Thomas C, Macgill RS, Neill P and Pardini RS: The in vitro and in vivo photoinduced antineoplastic activity of hypericin. Proc Amer Assoc Cancer Res 33: 5001, 992.
13. Falk H, Meyer J and Oberreiter M: A convenient semi-synthetic route to hypericin. Monatsh Chem 124: 339-341, 1993.
14. Freeman D, Frolow F, Kapinus E, Lavie D, Lavie G, Meruelo D and Mazur Y: Acidic properties of hypericin and its octahydroxy analog in the ground and excited states. J Chem Soc Chem Commun 7: 891-892, 1994.
15. Koren H, Alth G, Schenk GM and Jindra RH: Photodynamic therapy -an alternative pathway in the treatment of recurrent breast cancer. Int J Radial Oncol Biol Phys 28: 463-466, 1994.
16. McRipley RJ, Burns-Horwitz PE, Czemiak PM, Diamond RJ, Diamond MA, Miller JLD, Page RJ, Dexter DL, Chen S-F, Sun J-H, Behrens CH, Seitz SP and Gross JL: Efficacy of DMP 840: A novel bis-naphthalimide cytotoxic agent with human solid tumor xenograft selectivity. Cancer Res 54: 159-164, 1994.
17. Liebes L, Mazur Y, Freeman D. Lavie D, Lavie G, Kudler N, Mendoza S. Levin B, Hochster H and Meruelo D: A method for the quantitation of hypericin, an antiviral agent, in biological fluids by high-performance liquid chromatography. Anal Biochem 195: 77-85, 1991.
18. Katsumi T, Aizawa K, Okunaka T, Kuroiwa Y, Ii Y, Saito K, Konaka C and Kato H: Photodynamic therapy using a diode laser with mono-L-aspartyl chlorin e6 for implanted fibrosarcoma in mice. Jpn J Cancer Res 85: 1165-1170, 1994.
19. Dougherty TJ and Marcus SL: Photodynamic therapy. Eur J Cancer 28A: 1734-1742, 1992.
20. Krosl G, Korbelik M and Dougherty GJ: Induction of immune cell infiltration into murine SCCVII tumour by Photofrin-based photodynamic therapy. Br J Cancer 71: 549-555, 1995.
21. Rehg JE: Activity of azithromycin against cryptosporidia in immunosuppressed rats. J Infect Dis 163: 1293-1296, 1991.
22. Hudson JB, Lopez-Bazzocchi I and Towers GHN: Antiviral activities of hypericin. Antiviral Res 15: 101-112, 1991.
23. Jardon P, Lazorchak N and Gautron R: Proprietés du premier état triplet de l'hypericine étude par spectroscopie laser. J Chim Phys 83: 311-315, 1986.
24. Diwu Z: Novel therapeutic and diagnostic applications of hypocrellins and hypericins. Photochem Photobiol 6: 529-539, 1995.
25. Star WM, Marijnissen JPA, van den Berg-Blok AE, Versteeg MC, Franken KAP and Reinhold HS: Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res 46: 2532-2540, 1986.
26. Fehr MJ, Carpenter SL and Petrich JW: The role of oxygen in the photoinduced antiviral activity of hypericin. Bioorg Med Chem Lett 4: 1339-1344, 1994.
27. Diwu Z and Lown JW: Photosensitization with anticancer agents. 17. EPR studies of photodynamic action of hypericin: formation of semiquinone radical and activated oxygen species on illumination. Free Radic Biol Med 14: 209-215, 1993.